# Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)

Study · id `cardio:ct-nct07779746` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07779746](<https://clinicaltrials.gov/study/NCT07779746>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07779746

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Stroke; Heart rhythm problems; Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 848 participants.

## Technical summary

Registry record NCT07779746. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 848 participants (planned count; ClinicalTrials.gov record NCT07779746, source copy `cardio:ctgov-nct07779746-2026-08-21`, retrieved 2026-10-26)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07779746, source copy `cardio:ctgov-nct07779746-2026-08-21`, retrieved 2026-10-26)
- Primary completion: 2031-11 (anticipated) (ClinicalTrials.gov record NCT07779746, source copy `cardio:ctgov-nct07779746-2026-08-21`, retrieved 2026-10-26)
- Completion: 2032-11 (anticipated) (ClinicalTrials.gov record NCT07779746, source copy `cardio:ctgov-nct07779746-2026-08-21`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07779746-2026-08-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
- Acronym: SAFE-D2
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Condition: End Stage Kidney Disease (ESRD)
- Condition: Dialysis Patients
- Intervention (Drug): Eliquis
- Intervention (Other): No oral anticoagulation
- Lead sponsor: Unity Health Toronto
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Apixaban (Eliquis) (`cardio:eliquis`)
- Registry intervention name is a brand that an FDA record in the corpus ties to this substance: Apixaban (`cardio:apixaban`)
- Registry lists this organization as the lead sponsor: Unity Health Toronto (`cardio:org-unity-health-toronto`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

## Provenance

Content hash: 09d6271d65605d232e78870dc0bf9473cf2dd8f570c329da5c9bd12eb578aa6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
